MVA-MUC1-IL2

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

6 competitors in Carcinoma, Non-Small-Cell Lung

Drug Information

Target Indication

Carcinoma, Non-Small-Cell Lung

Clinical Trial

Last updated: 2/14/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

ALTRO.PA

Transgene

Related Pipeline

Squamous Cell Carcinoma of Head and Neck

HPV-Related Carcinoma

Non Small Cell Lung Cancer Metastatic

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts